Skip to main content
OpenTrials

Clinical trial condition

Ductal Breast Carcinoma In Situ

Explore clinical trials studying Ductal Breast Carcinoma In Situ. Study availability and eligibility vary by location and protocol.

35 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Ductal Breast Carcinoma In Situ trial results

Recruiting

The PREDICT Registry:

NCT03448926

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +14 more
Locations
  • Arizona Center for Cancer Care Scottsdale, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Sutter Health San Mateo, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View all 30 locations
View Trial Details
Completed

The PROMISE Study: Duavee in Women With DCIS

NCT02694809

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations
  • University of Colorado at Denver/ Department of Surgery Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • Northwestern Medicine - Delnor/Warrenville Cancer Centers/Central DuPage Hospital Geneva, Illinois, United States
  • Northwestern University Lake Forest, Illinois, United States
View Trial Details
Completed

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

NCT02993159

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Saint Elizabeth Medical Center South Edgewood, Kentucky, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions